Mirae Asset Global ETFs Holdings
ADVM

Mirae Asset Global ETFs Holdings’s Adverum Biotechnologies ADVM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,618
Closed -$55.1K – 3002
2025
Q1 		$55.1K Buy
12,618
+546
+5% +$2.46K ﹤0.01% 2827
2024
Q4 		$56.4K Buy
12,072
+532
+5% +$3.58K ﹤0.01% 2877
2024
Q3 		$81K Buy
+11,540
New +$83.8K ﹤0.01% 2791

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ADVM Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 12,618 shares — an estimated $55.1K sold.

Mirae Asset Global ETFs Holdings first reported a position in ADVM in Q3 2024 and held it in 3 quarters. The position peaked at $81K in Q3 2024. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 12,618 Adverum Biotechnologies shares in Q2 2025, an estimated $55.1K.
  • Mirae Asset Global ETFs Holdings first reported a position in Adverum Biotechnologies in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Adverum Biotechnologies position peaked at $81K in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.